Navigation Links
DelSite Chairman George DeMott Resigns
Date:12/11/2008

Board Appoints Carlton Turner as Chairman, Robert Schnitzius as Acting President & CEO

IRVING, Texas, Dec 11 /PRNewswire-FirstCall/ -- DelSite, Inc. (OTC Bulletin Board: DSII.OB), a drug delivery technology company, today announced that George DeMott, chairman of the board of directors for the Company, has resigned his position as chairman, effective immediately. Mr. DeMott will continue to serve on the board until his term ends in May 2009.

The board of directors of DelSite, Inc., named Dr. Carlton Turner as chairman. Dr. Turner is retiring from his position as president and CEO as of December 31, 2008. The board has also appointed Robert Schnitzius, the company's chief financial officer, as acting president and CEO, effective January 1, 2009.

Mr. DeMott has been the board's chairman since 1995. He has overseen the transition of Carrington Laboratories, Inc. from a wound care manufacturing company with basic R&D into a vaccine and drug delivery company.

DelSite Biotechnologies, Inc (DSBI) was established as a wholly-owned subsidiary of Carrington in 2001. DSBI's business plan was to develop Carrington's proprietary vaccine and drug delivery technology. Under Mr. DeMott's leadership and based on DSBI advancements, Carrington exited the wound care business and changed its name from Carrington Laboratories to DelSite, Inc. in June of this year.

DelSite continues to transition itself into a more traditional biotech company focused on delivery platforms for vaccines and drugs. Core technology is a naturally occurring linear, negatively charged carbohydrate polymer with the ability to stabilize proteins and peptides.

Mr. DeMott said, "DelSite has completed the Phase I safety of our nasal powder delivery platform GelVac(TM) and has also filed an IND for a Phase I effectiveness and safety study of a GelVac(TM) formulated influenza va
'/>"/>

SOURCE DelSite, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Carringtons DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office
2. Carringtons DelSite Presentation at Rodman & Renshaw Conference to be Webcast Live on November 7th
3. Carrington Subsidiary DelSite to Present at Investor Conference
4. Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland
5. Statement of DNC Chairman Howard Dean on World AIDS Day
6. Cardiome Discloses Chairman And CEOs Involuntary Share Sale
7. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
8. MDS Inc. Announces Appointment of James S.A. MacDonald as Chairman of Board of Directors
9. AMERIGROUP Chairman and CEO Urges Action to Improve Nations Premature Birth Report Card
10. As Chairman Baucus Outlines Vision for Healthcare Reform, NACDS Emphasizes Pharmacy's Essential Role in Any Successful Overhaul
11. The Foundation for Biomedical Research Names Dr. Hiram C. Polk Jr. Chairman of its Board of Governors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... scientists have shown that a new drug could prove useful ... form of lung cancer. , Scientists from the Cancer Research ... part of the Manchester Cancer Research Centre, teamed up with ... 2010, to test a drug known as AZD3965 - ... in the journal Clinical Cancer Research , also helps ...
(Date:7/9/2014)... episodes of low back pain are not linked to ... direction and precipitation. Findings published in Arthritis Care ... of Rheumatology (ACR), indicate that the risk of low ... wind gusts, but was not clinically significant. , ... experiences low back pain at some point in their ...
(Date:7/9/2014)... After Susan Wakulich was told she had an aneurysm, ... ahead of her. , "I was devastated," said Wakulich, who ... "I knew this was a serious diagnosis. Then I met ... that involved a less invasive procedure. It was something I ... participating in a multi-center U.S. clinical trial to evaluate the ...
(Date:7/9/2014)... of stromal support cells and immune cells and ... in the development of diseases could open new ... was the conclusion of a review article by scientists ... Nature . , Prof. Peter Carmeliet: "Consider the ... of cancer cells has been examined in minute detail ...
(Date:7/9/2014)... The Miriam Hospital have found that people with ... depressed have difficulty sticking to a pulmonary rehabilitation ... women, and screening and brief treatment of depression ... study and its findings are published in print ... obstructive pulmonary disease is a common and often ...
Breaking Medicine News(10 mins):Health News:New drug active against most aggressive type of lung cancer cells 2Health News:Low back pain? Don't blame the weather 2Health News:New type of stent could help some brain aneurysm patients 2Health News:Wake-up call for more research into cell metabolism 2Health News:Miriam Hospital study examines effect of depressed mood on pulmonary rehab completion 2
... be saved every year, thanks to a simple online calculator ... having ovarian cancer at a much earlier stage. Academics ... a new QCancer algorithm using the UK QResearch database. The ... factors to red flag those most likely to have ovarian ...
... (HealthDay News) --Families hoping to improve their fitness and overall ... TV or computer screen and more time being active together, according ... the following tips to help your family get moving and stay ... Stroll together after a family meal or walk around the mall ...
... The current issue of Medical Acupuncture , a ... how the U.S. military is incorporating medical acupuncture to ... in the war zones and the efforts underway to ... online at http://www.liebertpub.com/acu . "The use of ...
... press release is available in French . ... liver during digestion, has been seriously underestimated. A study published ... kill several types of cancer cells, such as those found ... research team, led by Concordia University, included scientists from McGill ...
... bowel disease (IBD) are increasing with time and in ... study in Gastroenterology , the official journal of ... worldwide epidemiology of inflammatory bowel disease is important for ... Gilaad G. Kaplan, MD, MPH, of the University of ...
... substances in licorice used extensively in Chinese traditional medicine ... and gum disease, the leading causes of tooth loss in ... of Natural Products , they say that these substances could ... gum disease. Stefan Gafner and colleagues explain that ...
Cached Medicine News:Health News:Simple online tool to aid GPs in early ovarian cancer diagnosis 2Health News:Simple online tool to aid GPs in early ovarian cancer diagnosis 3Health News:Cancer-killing compound spares healthy cells 2Health News:IBD emerges as a global disease 2
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... the needs of the higher risk ... features the PneumaticWalker for Diabetics. Similar ... Diabetics incorporates an innovative dual density ... insole, when combined with the semi-rigid ...
... Sarmiento style Patella-Tendon-Bearing brace is designed for ... tibia and fibula. The tibial crest provides ... medullary nailing and removal of internal or ... of joints above and below the fracture ...
... VACOPED is a revolutionary cast replacement ... the lower leg and foot. , ... patient's anatomy and in conjunction with a ... the general time of fracture or rupture ...
... combines the therapeutic benefits of controlled compression ... to minimize pain. The cuff is anatomically ... maximum cryotherapy.,All Cryo/Cuffs can be ordered as ... (including a tube assembly and insulation disk). ...
Medicine Products: